Guan H [31] reported that the BRD4/AR signaling pathway was significantly activated when progressing from ADPC to CRPC, and miR-200a could suppress prostate cancer progression by inhibiting this signaling pathway. The gene discussed is BRD4; the disease is prostate carcinoma.